Mesoblast (MESO) EBT Margin Growth (1y) (2017 - 2023)
Mesoblast (MESO) EBT Margin Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 813.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 741,325.00 |
| Mar 31, 2023 | -9,988.00 |
| Dec 31, 2022 | 50,425.00 |
| Sep 30, 2022 | -17,417.00 |
| Jun 30, 2022 | -365,199.00 |
| Mar 31, 2022 | 242,070.00 |
| Dec 31, 2021 | 187,915.00 |
| Sep 30, 2021 | 287,424.00 |
| Jun 30, 2021 | -97,175.00 |
| Mar 31, 2021 | -53,180.00 |
| Dec 31, 2020 | 22,064.00 |
| Sep 30, 2020 | -233,286.00 |
| Jun 30, 2020 | 107,848.00 |
| Mar 31, 2020 | 178,057.00 |
| Dec 31, 2019 | 89,332.00 |
| Sep 30, 2019 | -144,942.00 |
| Jun 30, 2019 | 7,039.00 |
| Mar 31, 2019 | -12,936.00 |
| Dec 31, 2018 | -209,373.00 |
| Sep 30, 2018 | 269,055.00 |